Screener
Trevi Therapeutics, Inc. TRVI Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Trevi Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206390
FAQ
- What is Trevi Therapeutics, Inc.'s debt-to-equity?
- Trevi Therapeutics, Inc. (TRVI) reported debt-to-equity of 0× in Q1 2026.
- How has Trevi Therapeutics, Inc.'s debt-to-equity changed year-over-year?
- Trevi Therapeutics, Inc.'s debt-to-equity decreased by 58.3% year-over-year, from 0× to 0×.
- What is the long-term trend for Trevi Therapeutics, Inc.'s debt-to-equity?
- Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s debt-to-equity has grown at a -15.3% compound annual growth rate (CAGR), from 0× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Trevi Therapeutics, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude